...
首页> 外文期刊>Advances in renal replacement therapy >Racial and ethnic differences in the incidence and progression of focal segmental glomerulosclerosis in children.
【24h】

Racial and ethnic differences in the incidence and progression of focal segmental glomerulosclerosis in children.

机译:儿童局灶性节段性肾小球硬化症的发生和发展的种族和种族差异。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Idiopathic focal segmental glomerulosclerosis (FSGS) is a common cause of nephrotic syndrome in pediatric and adult patients. Most children with FSGS do not respond to any form of therapy and progress to end-stage renal disease (ESRD). FSGS reoccurs in the transplanted kidney in approximately one third of initial transplants and in a substantially higher percentage of subsequent transplants once FSGS has recurred in an earlier transplant. Thus, FSGS is a disease with substantial morbidity. Over the past several years, the incidence of FSGS in adults and children appears to be increasing, particularly in certain racial groups and ethnic populations. Several recent studies in adult and pediatric patients suggest that the incidence of FSGS is increasing particularly in the black population. In addition, some studies have also demonstrated a more rapid progression of FSGS to ESRD in black patients compared to other ethnic groups. Racial and ethnic background is likely to have a substantial influence on theincidence and progression of FSGS in children and adults. It is likely that specific genes or a combination of genes influence the different clinical manifestations of FSGS in racial and ethnic groups. Genetic mutations in NPHS1 gene, which encodes nephrin, have been found to cause congenital nephrotic syndrome. Genetic mutations in the NPHS2 gene, which encodes podocin, recently have been shown to be strongly associated with a recessive form of steroid-resistant nephrotic syndrome. Mutations in the ACTN4 gene that encodes actinin 4 has also been associated with familial nephrotic syndrome. A role for ACE polymorphisms in the progression of FSGS has been found in some studies. Future investigations to identify polymorphisms that influence the development of FSGS, the progression of FSGS, and the response to therapy will greatly improve understanding of the pathogenesis and management of FSGS.
机译:特发性局灶性节段性肾小球硬化症(FSGS)是小儿和成人患者肾病综合征的常见病因。大多数患有FSGS的儿童对任何形式的治疗均无反应,并进展为终末期肾病(ESRD)。一旦在早期移植中复发,FSGS就会在移植的肾脏中约三分之一的原始移植物中再次发生,并且在随后移植中的百分比会更高。因此,FSGS是具有高发病率的疾病。在过去的几年中,成人和儿童中FSGS的发病率似乎正在增加,特别是在某些种族群体和族裔人群中。近期针对成人和儿科患者的几项研究表明,FSGS的发病率正在增加,尤其是在黑人人群中。此外,一些研究还表明,与其他种族相比,黑人患者中FSGS向ESRD的进展更快。种族和族裔背景可能对儿童和成人FSGS的发生和发展产生重大影响。特定基因或基因组合可能会影响种族和族裔中FSGS的不同临床表现。已发现编码肾素的NPHS1基因的遗传突变会导致先天性肾病综合征。 NPHS2基因的基因突变编码Podocin,最近已显示出与激素抵抗性肾病综合征的隐性形式密切相关。编码肌动蛋白4的ACTN4基因突变也与家族性肾病综合征有关。在一些研究中发现了ACE多态性在FSGS进展中的作用。未来的研究将确定影响FSGS的发展,FSGS的进展以及对治疗的反应的多态性,这将大大提高对FSGS的发病机理和治疗方法的了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号